JP2025508785A5 - - Google Patents

Info

Publication number
JP2025508785A5
JP2025508785A5 JP2024549489A JP2024549489A JP2025508785A5 JP 2025508785 A5 JP2025508785 A5 JP 2025508785A5 JP 2024549489 A JP2024549489 A JP 2024549489A JP 2024549489 A JP2024549489 A JP 2024549489A JP 2025508785 A5 JP2025508785 A5 JP 2025508785A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
halogens
halogen
conjugate according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549489A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508785A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062996 external-priority patent/WO2023164464A1/en
Publication of JP2025508785A publication Critical patent/JP2025508785A/ja
Publication of JP2025508785A5 publication Critical patent/JP2025508785A5/ja
Pending legal-status Critical Current

Links

JP2024549489A 2022-02-22 2023-02-22 5’修飾炭素環式リボヌクレオチド誘導体及び使用方法 Pending JP2025508785A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263312554P 2022-02-22 2022-02-22
US63/312,554 2022-02-22
PCT/US2023/062996 WO2023164464A1 (en) 2022-02-22 2023-02-22 5'-modified carbocyclic ribonucleotide derivatives and methods of use

Publications (2)

Publication Number Publication Date
JP2025508785A JP2025508785A (ja) 2025-04-10
JP2025508785A5 true JP2025508785A5 (cg-RX-API-DMAC7.html) 2026-03-03

Family

ID=85778954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549489A Pending JP2025508785A (ja) 2022-02-22 2023-02-22 5’修飾炭素環式リボヌクレオチド誘導体及び使用方法

Country Status (9)

Country Link
US (1) US12636301B2 (cg-RX-API-DMAC7.html)
EP (1) EP4482845A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025508785A (cg-RX-API-DMAC7.html)
KR (1) KR20240169616A (cg-RX-API-DMAC7.html)
CN (1) CN118922431A (cg-RX-API-DMAC7.html)
AU (1) AU2023224208A1 (cg-RX-API-DMAC7.html)
CA (1) CA3252536A1 (cg-RX-API-DMAC7.html)
IL (1) IL314850A (cg-RX-API-DMAC7.html)
WO (1) WO2023164464A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024081954A2 (en) 2022-10-14 2024-04-18 Sanegene Bio Usa Inc. Small interfering rna targeting c3 and uses thereof
IL323663A (en) * 2023-04-06 2025-11-01 Shanghai Argo Biopharmaceutical Co Ltd Nucleoside analog for 5'-phosphonate modification and oligonucleotide prepared therefrom
WO2025191337A2 (en) * 2024-03-11 2025-09-18 Synerk Biotech Limited Oligonucleotide terminal phosphate derivatives and method of use
WO2026017140A2 (en) 2024-07-18 2026-01-22 Sanegene Bio Usa Inc. Small interfering rna targeting fxi and uses thereof
WO2026041067A2 (en) 2024-08-20 2026-02-26 Sanegene Bio Usa Inc. Small interfering rna targeting myostatin (mstn) and uses thereof
WO2026046411A1 (en) 2024-09-02 2026-03-05 Sanegene Bio Usa Inc. Small interfering rna targeting plasminogen (plg) and uses thereof
US12454693B1 (en) 2024-09-27 2025-10-28 Dexcel Pharma Technologies Ltd. Nucleic acids for inhibiting expression of transferrin receptor 2
WO2026092658A2 (en) 2024-10-31 2026-05-07 Sanegene Bio Usa Inc. Small interfering rna targeting amyloid beta precursor protein (app) and uses thereof
US20260226475A1 (en) 2025-01-27 2026-08-06 Sanegene Bio Usa Inc. Small interfering rna targeting acvr1c and uses thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1154A (en) 1839-05-17 Spiral-bucket watek-wheel
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5453566A (en) 1986-03-28 1995-09-26 Calgene, Inc. Antisense regulation of gene expression in plant/cells
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
CA1340323C (en) 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
GB8822492D0 (en) 1988-09-24 1988-10-26 Considine J Apparatus for removing tumours from hollow organs of body
CA2039718C (en) 1989-08-31 2003-02-25 John J. Rossi Chimeric dna-rna catalytic sequences
US6365730B1 (en) 1990-06-19 2002-04-02 Gene Shears Pty. Limited DNA-Armed ribozymes and minizymes
US5789573A (en) 1990-08-14 1998-08-04 Isis Pharmaceuticals, Inc. Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
AU649074B2 (en) 1990-10-12 1994-05-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
DE4216134A1 (de) 1991-06-20 1992-12-24 Europ Lab Molekularbiolog Synthetische katalytische oligonukleotidstrukturen
US5652094A (en) 1992-01-31 1997-07-29 University Of Montreal Nucleozymes
CA2135646A1 (en) 1992-05-11 1993-11-25 Kenneth G. Draper Method and reagent for inhibiting viral replication
JPH07509133A (ja) 1992-07-17 1995-10-12 リボザイム・ファーマシューティカルズ・インコーポレイテッド 動物疾患の処置のための方法および剤
IL108367A0 (en) 1993-01-27 1994-04-12 Hektoen Inst For Medical Resea Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells
US5591317A (en) 1994-02-16 1997-01-07 Pitts, Jr.; M. Michael Electrostatic device for water treatment
US5631359A (en) 1994-10-11 1997-05-20 Ribozyme Pharmaceuticals, Inc. Hairpin ribozymes
AU3889595A (en) 1994-10-05 1996-05-02 Amgen, Inc. Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein
US5783683A (en) 1995-01-10 1998-07-21 Genta Inc. Antisense oligonucleotides which reduce expression of the FGFRI gene
US5747470A (en) 1995-06-07 1998-05-05 Gen-Probe Incorporated Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US5739119A (en) 1996-11-15 1998-04-14 Galli; Rachel L. Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA
CA2518475C (en) 2003-03-07 2014-12-23 Alnylam Pharmaceuticals, Inc. Irna agents comprising asymmetrical modifications
EP2669377A3 (en) 2003-04-17 2015-10-14 Alnylam Pharmaceuticals Inc. Modified iRNA agents
AU2006279906B2 (en) 2005-08-10 2012-05-10 Alnylam Pharmaceuticals, Inc. Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
EP2229186A2 (en) 2007-12-04 2010-09-22 Alnylam Pharmaceuticals Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
WO2011139699A2 (en) 2010-04-28 2011-11-10 Isis Pharmaceuticals, Inc. 5' modified nucleosides and oligomeric compounds prepared therefrom
WO2011139702A2 (en) * 2010-04-28 2011-11-10 Isis Pharmaceuticals, Inc. Modified nucleosides and oligomeric compounds prepared therefrom
RU2582235C2 (ru) 2010-12-29 2016-04-20 Ф.Хоффманн-Ля Рош Аг Низкомолекулярные конъюгаты для внутриклеточной доставки нуклеиновых кислот
US8577565B2 (en) 2011-12-16 2013-11-05 GM Global Technology Operations LLC Limiting branch pressure to a solenoid valve in a fluid circuit
EP2958998B1 (en) * 2013-02-22 2017-12-27 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) molecules containing a 2' internucleoside linkage
WO2015006740A2 (en) 2013-07-11 2015-01-15 Alnylam Pharmaceuticals, Inc. Oligonucleotide-ligand conjugates and process for their preparation
EP3865576A1 (en) 2014-12-15 2021-08-18 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids
TWI912633B (zh) 2016-06-06 2026-01-21 美商愛羅海德製藥公司 5'-環-磷酸修飾之核苷酸
MX2019002075A (es) 2016-08-23 2019-07-01 Dicerna Pharmaceuticals Inc Composiciones que comprenden oligonucleotidos modificados reversiblemente, y sus usos.
WO2018045317A1 (en) 2016-09-02 2018-03-08 Dicerna Pharmaceuticals, Inc. 4'-phosphate analogs and oligonucleotides comprising the same

Similar Documents

Publication Publication Date Title
JP2024529067A5 (cg-RX-API-DMAC7.html)
JP2024534502A5 (cg-RX-API-DMAC7.html)
JP7740719B2 (ja) ホスホルアミダイト化学を使用する骨格修飾モルホリノオリゴヌクレオチド及びキメラの合成
JP7008056B2 (ja) 修飾されたサブユニット間結合および/または末端基を有するオリゴヌクレオチドアナログ
JP2025041652A5 (cg-RX-API-DMAC7.html)
US9273086B2 (en) Protected monomer and method of final deprotection for RNA synthesis
US10066228B2 (en) Oligonucleotides for treating expanded repeat diseases
ES2924806T3 (es) Análogos de 4'-fosfato y oligonucleótidos que comprenden el mismo
US12503698B2 (en) GalNAc derivatives
CN106188192B (zh) 含d-氨基酸酯的核苷氨基磷酸/膦酸酯衍生物及其医药用途
CN1964967B (zh) 路易斯酸介导的环状酯的合成
JP2023541427A (ja) 骨格筋送達プラットフォーム及び使用方法
JP2021533800A5 (cg-RX-API-DMAC7.html)
JP2021535226A5 (cg-RX-API-DMAC7.html)
JP2022535911A5 (cg-RX-API-DMAC7.html)
US20120184724A1 (en) Protected monomers and methods of deprotection for rna synthesis
US20170362270A1 (en) Modified oligonucleotides and methods for their synthesis
JP2015501817A5 (cg-RX-API-DMAC7.html)
JP2022527569A5 (cg-RX-API-DMAC7.html)
JP2021522862A5 (cg-RX-API-DMAC7.html)
JP2015063538A (ja) ヌクレオシドホスホナートが投与された被験者における腎毒性を減少させる方法
JP2024546667A5 (cg-RX-API-DMAC7.html)
CA2436665A1 (en) Nucleic acid derivatives
CN104023751B (zh) 靶向递送至表达vla-4的细胞的整联蛋白拮抗剂结合物
US6900307B1 (en) 2-aminopurine derivatives